JP2021513865A5 - - Google Patents
Info
- Publication number
- JP2021513865A5 JP2021513865A5 JP2020544642A JP2020544642A JP2021513865A5 JP 2021513865 A5 JP2021513865 A5 JP 2021513865A5 JP 2020544642 A JP2020544642 A JP 2020544642A JP 2020544642 A JP2020544642 A JP 2020544642A JP 2021513865 A5 JP2021513865 A5 JP 2021513865A5
- Authority
- JP
- Japan
- Prior art keywords
- streptococcus
- group
- amino acid
- modified lysin
- lysin polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635515P | 2018-02-26 | 2018-02-26 | |
| US62/635,515 | 2018-02-26 | ||
| PCT/US2019/019638 WO2019165454A1 (en) | 2018-02-26 | 2019-02-26 | Modified plyss2 lysins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021513865A JP2021513865A (ja) | 2021-06-03 |
| JP2021513865A5 true JP2021513865A5 (enExample) | 2022-02-09 |
Family
ID=67687985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544642A Pending JP2021513865A (ja) | 2018-02-26 | 2019-02-26 | 修飾ＰｌｙＳｓ２溶解素及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210032294A1 (enExample) |
| EP (1) | EP3758738A4 (enExample) |
| JP (1) | JP2021513865A (enExample) |
| KR (1) | KR20200124724A (enExample) |
| CN (1) | CN112118861A (enExample) |
| AU (1) | AU2019224160A1 (enExample) |
| BR (1) | BR112020017219A2 (enExample) |
| CA (1) | CA3092109A1 (enExample) |
| IL (1) | IL276807A (enExample) |
| MX (1) | MX2020008860A (enExample) |
| RU (1) | RU2020128276A (enExample) |
| WO (1) | WO2019165454A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3980049A4 (en) * | 2019-04-11 | 2023-07-19 | Contrafect Corporation | METHOD OF TREATMENT AND PREVENTION OF BONE AND JOINT INFECTIONS |
| WO2021236636A1 (en) * | 2020-05-19 | 2021-11-25 | Contrafect Corporation | MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA |
| WO2023049747A1 (en) * | 2021-09-22 | 2023-03-30 | Elanco Us Inc. | Streptococcus suis lytic enzyme compositions and methods of use thereof |
| WO2023081691A1 (en) * | 2021-11-04 | 2023-05-11 | Contrafect Corporation | Method of treating and preventing bone and joint infections |
| CN115851689A (zh) * | 2022-08-09 | 2023-03-28 | 中南民族大学 | 一种嵌合裂解酶PlySs2E-V12C及其应用、重组质粒和重组菌株 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2833409A1 (en) * | 2011-04-21 | 2012-10-26 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| CN103703127A (zh) * | 2011-05-04 | 2014-04-02 | 迈克瑞欧斯人体健康有限公司 | 一种多肽 |
| KR20210121313A (ko) * | 2012-05-09 | 2021-10-07 | 콘트라펙트 코포레이션 | 그람 양성 박테리아에 대한 박테리오파지 리신과 항생제의 병용물 |
| KR20200023521A (ko) * | 2012-05-09 | 2020-03-04 | 콘트라펙트 코포레이션 | 박테리오파지 리신을 이용한 생물막의 예방, 붕괴 및 치료 |
| CN104073478A (zh) * | 2014-06-13 | 2014-10-01 | 上海交通大学 | 杀灭革兰氏阳性菌的酶抗生素及其制备、用途 |
| CN104211781A (zh) * | 2014-09-04 | 2014-12-17 | 北京纳百景弈生物科技有限公司 | 金黄色葡萄球菌裂解蛋白的制备方法及其应用 |
| KR20190004799A (ko) * | 2016-05-12 | 2019-01-14 | 콘트라펙트 코포레이션 | 항균 폴리펩티드의 최소 억제 농도를 평가 및 탐지하기 위한 배지미량희석법 |
-
2019
- 2019-02-26 KR KR1020207027681A patent/KR20200124724A/ko not_active Ceased
- 2019-02-26 BR BR112020017219-7A patent/BR112020017219A2/pt not_active IP Right Cessation
- 2019-02-26 EP EP19757130.0A patent/EP3758738A4/en active Pending
- 2019-02-26 AU AU2019224160A patent/AU2019224160A1/en not_active Abandoned
- 2019-02-26 MX MX2020008860A patent/MX2020008860A/es unknown
- 2019-02-26 WO PCT/US2019/019638 patent/WO2019165454A1/en not_active Ceased
- 2019-02-26 US US16/975,321 patent/US20210032294A1/en not_active Abandoned
- 2019-02-26 CN CN201980027962.7A patent/CN112118861A/zh active Pending
- 2019-02-26 JP JP2020544642A patent/JP2021513865A/ja active Pending
- 2019-02-26 RU RU2020128276A patent/RU2020128276A/ru unknown
- 2019-02-26 CA CA3092109A patent/CA3092109A1/en active Pending
-
2020
- 2020-08-19 IL IL276807A patent/IL276807A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513865A5 (enExample) | ||
| Al Atya et al. | Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation | |
| Mathur et al. | Fighting biofilms with lantibiotics and other groups of bacteriocins | |
| JP2022058682A5 (enExample) | ||
| RU2020128276A (ru) | МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| Gibbons et al. | The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet (K) determinant | |
| RU2014149351A (ru) | Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий | |
| RU2018102796A (ru) | Предотвращение, разрушение и обработка биопленки лизином бактериофага | |
| JP2021519083A5 (enExample) | ||
| Fan et al. | Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria | |
| Wladyka et al. | Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91 | |
| EP3164146B1 (en) | Acinetobacter lysins | |
| RU2018107249A (ru) | Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики | |
| Basi-Chipalu et al. | A review on characterization, applications and structure-activity relationships of Bacillus species-produced bacteriocins | |
| WO2009111064A3 (en) | Minocycline compounds and methods of use thereof | |
| Rahimzadeh et al. | Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review. | |
| MX2021015563A (es) | Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes. | |
| Irani et al. | The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii | |
| WO2010041970A3 (en) | Antibacterial phage peptides and methods of use thereof | |
| JP2017533177A5 (enExample) | ||
| HRP20200195T1 (hr) | Antibiotske terapije na bazi peptida porijeklom od vodenog bivola | |
| Chen et al. | Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against “ESKAPEE” pathogens | |
| Abraham et al. | A tick antivirulence protein potentiates antibiotics against Staphylococcus aureus | |
| Ulm et al. | Targeting bactoprenol-coupled cell envelope precursors | |
| KR101818499B1 (ko) | 포도상구균 박테리오파지 유래 신규 엔도라이신 LysSA97과 에센셜 오일 성분을 함유하는 세균 사멸용 조성물 |